Sutureless Valve in Repeated Aortic Valve Replacement: Results from an International Prospective Registry
Mattia Glauber, William DT Kent, George Asimakopoulos, Giovanni Troise, Josep Maria Padro, Alistair Royse, Jean-Marc Marnette, Philippe Noirhomme, Max Baghai, Michael Lewis, Lorenzo Di Bacco, Marco Solinas, Antonio Miceli
INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY | SAGE PUBLICATIONS INC | Published : 2021
OBJECTIVE: To report early and midterm results registry of patients undergoing repeated aortic valve replacement (RAVR) with sutureless prostheses from an international prospective registry (SURE-AVR). METHODS: Between March 2011 and June 2019, 69 patients underwent RAVR with self-expandable sutureless aortic bioprostheses at 22 international cardiac centers. RESULTS: Overall mortality was 2.9% with a predicted logistic EuroSCORE II of 10.7%. Indications for RAVR were structural valve dysfunction (84.1%) and infective prosthetic endocarditis (15.9%) and were performed in patients with previously implanted bioprostheses (79.7%), mechanical valves (15.9%), and transcatheter valves (4.3%). Mini..View full abstract
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The SURE-AVR registry is funded by LivaNova PLC.